Right now, the company trades at a forward price-to-earnings ratio (P/E) of about 12. That's roughly half the forward P/E of ...

Citrini Research’s post on AI risks appears to have sparked a stock selloff.

This study is a valuable contribution that comprehensively identifies and characterizes LC3B-binding peptides through a bacterial cell-surface display screen covering approximately 500,000 human ...